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 2 
Abstract 25 
Urinary tract infections (UTIs) are common, in general caused by intestinal Uropathogenic E. 26 
coli (UPEC) ascending via the urethra. Microcompartment-mediated catabolism of 27 
ethanolamine, a host cell breakdown product, fuels competitive overgrowth of intestinal E. 28 
coli, both pathogenic enterohaemorrhagic E. coli and commensal strains. During UTI urease 29 
negative E. coli thrive, despite the comparative nutrient limitation in urine. The role of 30 
ethanolamine as a potential nutrient source during UTI is understudied. We evaluated the role 31 
of metabolism of ethanolamine as a potential nitrogen and carbon source for UPEC in the 32 
urinary tract. We analysed infected urine samples by culture, HPLC, qRT-PCR and genomic 33 
sequencing. Ethanolamine concentration in urine was comparable to the most abundant 34 
reported urinary amino acid D-serine. Transcription of the eut operon was detected in the 35 
majority of urine samples screened containing E. coli. All sequenced UPECs had conserved 36 
eut operons while metabolic genotypes previously associated with UTI (dsdCXA, metE) were 37 
mainly limited to phylogroup B2. In vitro ethanolamine was found to be utilised as a sole 38 
source of nitrogen by UPECs. Metabolism of ethanolamine in artificial urine medium (AUM) 39 
induced metabolosome formation and provided a growth advantage at the physiological 40 
levels found in urine. Interestingly, eutE (acetaldehyde dehydrogenase) was required for 41 
UPECs to utilise ethanolamine to gain a growth advantage in AUM, suggesting ethanolamine 42 
is also utilised as a carbon source. This data suggests urinary ethanolamine is a significant 43 
additional carbon and nitrogen source for infecting E. coli. 44 
  45 
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 3 
Introduction 46 
Urinary tract infection is a common condition with an estimated 150 million episodes 47 
globally per annum (1). The most common identified cause is infection by uropathogenic 48 
Escherichia coli (UPEC) strains (2, 3). The currently accepted paradigm for uncomplicated 49 
urinary tract infection is that these E. coli strains residing in the gut as commensals 50 
successively colonise the perineum (4), the urethra and then the bladder, where the 51 
production of bacterial toxins and the host immune response lead to tissue damage and 52 
symptoms such as frequency and dysuria (2). Further ascending infection to colonise the 53 
kidney with more local tissue damage causing pyelonephritis and bacteraemia occurs in a 54 
small percentage of cases.  55 
 56 
Common genetic features have been noted in a variety of E. coli strains causing infections 57 
outside the gastrointestinal tract, including UPEC, and these are collectively termed ExPEC 58 
(extraintestinal pathogenic isolates of E. coli) (5, 6). Panels of genes whose presence is 59 
associated with any E. coli infection outside the gastrointestinal tract (7), or specifically 60 
urinary tract infection (8), have been assembled by genetic comparison of E. coli strains 61 
isolated from the gut with those isolated from urine and other extraintestinal sites and those 62 
known to be virulent in different animal models. However, the mechanism by which these 63 
factors are involved in pathogenicity is obscure.  64 
 65 
In the pathogenesis of E. coli urinary tract infection rapid invasion of bladder cells occurs 66 
with formation of intracellular bacterial communities (IBCs) with biofilm-like properties 67 
which initiate the infective process (9, 10). This bottleneck reduces diversity and has 68 
prevented global searches by signature tagged mutagenesis for key genetic factors required 69 
for infection (11). Assessing genome-sequenced clinical E. coli urinary isolates in a mouse 70 
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 4 
model of urinary tract infection showed that no set of genes was predictive of virulence in the 71 
model (12), including genes previously specifically associated with urovirulence.  72 
 73 
Rapid growth has been shown to be characteristic of early phase E. coli infection in the 74 
urinary tract (13), suggesting securing nutrition in the urinary tract is a key part of E. coli 75 
pathogenesis. E. coli requirements for central carbon metabolism in the urinary tract have 76 
been explored by competition studies with selected mutants in murine models. Interruption of 77 
gluconeogenesis (pckA) or the TCA cycle (sdhB) reduces fitness of E. coli to infect (14). This 78 
is in contrast to the nutrient rich intestine, where glycolysis (pgi) or the Entner-Douderoff 79 
(edd) pathway are required for colonisation fitness (15). 80 
 81 
Some metabolic loci have been linked to UPEC pathogenesis. D-serine is an abundant amino 82 
acid in human urine, present at a mean concentration of 0.12 mM (16), and up to 1mM in 83 
some cases (17), much higher than intestinal content levels. Some E. coli strains can 84 
metabolise D-serine to pyruvate and ammonia (18), allowing it to be a sole carbon and 85 
nitrogen source in vitro (19). This is conferred by possession of a complete D-serine 86 
tolerance locus (dsdCXA) (20), where dsdC encodes a LysR-type transcriptional regulator 87 
(LTTR), dsdX a D-serine transporter (21) and dsdA a D-serine dehydratase. ExPEC strains 88 
usually encode a full dsdCXA locus, while enteric pathogenic E. coli frequently have a 89 
truncation after dsdC (22). In the absence or truncation of this locus, D-serine shows 90 
reversible toxicity for E. coli causing growth arrest at concentrations of 0.1 mM and above in 91 
vitro (23).  92 
A metabolic regulatory polymorphism has been associated with cobalamin-independent 93 
methionine synthase (MetE) in UPEC. A promoter polymorphism (sra or short regulatory 94 
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 5 
allele) upstream of the metE gene in these strains is associated with increased metE induction 95 
and enhanced ability to grow in urine in vitro (24). 96 
 97 
Mutational analysis of a subset of E. coli genes showing a marked (>fourfold) increase in 98 
transcription in infected patient urine compared to growth in urine or Luria Broth (LB) (25) 99 
showed that that their knockout caused a fitness defect in the urinary bladder in a mouse 100 
model of ascending urinary infection. The most marked defects were with knockout of the 101 
cus (copper resistance) and eut (ethanolamine uptake and metabolism) operons.  102 
 103 
The eut operon is part of the conserved E. coli core genome (26) having arrived in 104 
Enterobacterales by horizontal transfer (27). It contains seventeen genes including the 105 
positive transcriptional regulator eutR. The operon encodes enzymes required for 106 
ethanolamine metabolism and includes structural shell protein genes for the synthesis of thin 107 
porous protein shells enclosing the enzymes as bacterial microcompartments 108 
(metabolosomes) in the cytoplasm (28–30) (Fig 1A). Experiments largely conducted with 109 
Salmonella enterica (which contains the same operon) suggest that the enzymic breakdown 110 
of ethanolamine to ammonia (a nitrogen source) and acetaldehyde occurs within the 111 
metabolosome, with the toxic effects and evaporative loss of acetaldehyde minimised by 112 
microcompartment enclosure and onward metabolism to ethanol and acetyl-CoA (a carbon 113 
source)(30, 31). Some acetyl-CoA is further metabolised to acetyl phosphate and acetate 114 
within the metabolosome, and some is available to enter central metabolism (32). 115 
Ethanolamine in the gastrointestinal tract utilised by this pathway gives a competitive 116 
advantage to Enterohaemorrhagic E. coli (33) and Salmonella enteritidis (34). Recently it has 117 
been shown that E. coli ethanolamine metabolism is essential for bladder colonisation in a 118 
murine model of ascending UTI (35). The mechanism was suggested to involve resistance to 119 
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 6 
innate immunity because the colonisation advantage of wild type UPEC over a △eutR mutant 120 
was abolished in neutrophil-depleted mice. Clearance of an isogenic △eutR mutant E. coli 121 
from the bladder coincided with peaking myeloperoxidase levels. However, resistance to 122 
hydrogen peroxide was unchanged in the △eutR mutant.  123 
 124 
In this study we evaluated the role of microcompartment-mediated ethanolamine metabolism 125 
in clinically infected urine samples and in laboratory cultures of E. coli strains isolated from 126 
infected urine. The eut operon was induced in infected urine, and ethanolamine was present 127 
in urine at a level that enhanced E. coli growth in vitro . Metabolosomes were visible on 128 
TEM in a UPEC strain grown with ethanolamine. Inactivation of the eut operon reduced 129 
growth of a UPEC strain in ethanolamine-containing nitrogen-limited minimal medium and 130 
growth and competitiveness in ethanolamine-containing artificial urine medium. Selective 131 
mutation of individual eut genes suggested that ethanolamine provided a carbon source in this 132 
artificial urine medium. In summary, we have identified that microcompartment-mediated 133 
metabolism of ethanolamine present in urine can give E. coli a growth advantage by 134 
providing an additional carbon and nitrogen source. 135 
 136 
Methods 137 
 138 
Bacterial strains and culture conditions 139 
Clinically infected urine samples received at Cork University Hospital (CUH) containing 140 
visible bacteria and white cells were selected and anonymised. The protocol was approved by 141 
the Clinical Research Ethics Committee of the Cork Teaching Hospitals ref ECM 4 (c) 142 
12/08/14. A further 12 specimens of macroscopically clear urine with no bacteria or white 143 
cells were selected as controls. Following initial culture on CLED agar pure colonies 144 
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 7 
subcultured on Columbia blood agar were identified by MALDI-TOF using a Microflex LT 145 
mass spectrometer (Bruker Daltonik) and the MALDI Biotyper software package (version 146 
3.0). Antimicrobial sensitivity was determined by the VITEK® 2.0 system (Biomérieux) 147 
using EUCAST breakpoints. Strains used for gene inactivation or competitive growth assays 148 
are listed in Table 1. Sixty-one E. coli strains were isolated, and whole genome sequences 149 
obtained for 47 strains. 150 
 151 
E. coli were routinely cultured in LB broth at 30 °C or 37 °C with aeration.To determine the 152 
ability to utilise ethanolamine, strains were cultured at 37 °C in modified M9 minimal media 153 
(33) containing 10 mM ethanolamine hydrochloride and 200 nM cobalamin with the addition 154 
of either 20mM glycerol or 20 mM ammonium chloride. Automated growth count cultures 155 
were incubated in 96-well plates in triplicate and OD600 measured using a Biotek Eon 156 
Microplate Spectrophotometer over 48 hours. Manual growth curves were measured in 35 ml 157 
volumes with spectrophotometric analysis of 1 ml aliquots.  158 
 159 
Competition experiments were carried out in a published liquid artificial urine medium 160 
(AUM) (36) and with the same medium with added ethanolamine hydrochloride at 0.5 mM, 161 
and 10 mM, with cell counts on LB agar. Pre-cultured E. coli strains were incubated in LB 162 
with antibiotics where appropriate. The cultures were washed in PBS and resuspended in 163 
AUM. Approximately equal concentrations of the wild type and isogenic mutant were used to 164 
inoculate AUM with ethanolamine as indicated in the text to give an approximate starting 165 
OD600 of 0.1. The co-cultures were incubated at 37ºC with aeration and at each time point 166 
the co-culture were diluted 10-fold in PBS and plated on to LB agar. The dilutions were 167 
plated onto LB agar and onto LB agar containing kanamycin to determine the concentration 168 
of each strain of E. coli. The plates were incubated overnight at 37°C and the CFU calculated. 169 
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 8 
The wild type CFU was calculated by subtracting the number of CFU resistant to kanamycin 170 
from the number of CFU on LB agar plates. The experiment was repeated three times and a 171 
competitive index was calculated as follows:  172 
 173 
𝐶𝐼 =
𝑒𝑢𝑡 𝑚𝑢𝑡𝑎𝑛𝑡 𝐶𝐹𝑈 𝑟𝑒𝑐𝑜𝑣𝑒𝑟𝑒𝑑 𝑊𝑖𝑙𝑑 𝑇𝑦𝑝𝑒 𝐶𝐹𝑈 𝑟𝑒𝑐𝑜𝑣𝑒𝑟𝑒𝑑⁄
𝑒𝑢𝑡 𝑚𝑢𝑡𝑎𝑛𝑡 𝐶𝐹𝑈 𝑖𝑛𝑜𝑐𝑢𝑙𝑢𝑚 𝑊𝑖𝑙𝑑 𝑡𝑦𝑝𝑒 𝐶𝐹𝑈 𝑖𝑛𝑜𝑐𝑢𝑙𝑢𝑚⁄
 
 174 
A competitive index below 1 indicates that the wild type was outcompeting the mutant strain 175 
at that time point. The CI at time zero is by definition 1.0 . Growth of eut operon mutants was 176 
compared with wild-type strains in M9 minimal medium with 0.5 mM and 10 mM 177 
ethanolamine and AUM with 10 mM ethanolamine. 178 
 179 
Mutants 180 
To generate deletion mutants, BW25113 knockout E. coli strains for the genes of interest 181 
were obtained from the Keio collection (37). Mutations were transferred to UPEC strain U1 182 
by P1vir phage transduction (38) In brief, lysogen strains were prepared by incubating P1 183 
lysate with the donor strain for 30 minutes at 30°C with 5µl of 1M CaCl2 and the culture 184 
were plated on kanamycin selective agar. The resulting colonies were used to prepare the 185 
lysate for transduction. Lysogen colonies were grown overnight in 2ml of LB at 30ºC. The 186 
precultures were used to inoculate LB and grown until reaching an OD600 of 0.2. The cultures 187 
were incubated in 46ºC for 20 minutes with shaking before being moved to 37°C until 188 
complete lysis. Bacteria were centrifuged out of the culture and the supernatant was stored 189 
with chloroform to prevent bacterial growth. Overnight cultures of the recipient strain were 190 
resuspended in transduction buffer (10mM MgSO4, 5mM CaCl2) and 100µl of cells were 191 
incubated with lysate and incubated at 37°C for 30 minutes. Sodium citrate was added 192 
following this incubation and for a further hour. The cells were washed in LB before being 193 
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 9 
plated onto LB agar plates. Strains were selected for kanamycin resistance and transductants 194 
were confirmed by genome sequencing and PCR using primers internal to the kanamycin 195 
gene and upstream and downstream of the disrupted gene (Supplementary Data Table S1). 196 
Complementation was with E. coli K-12 genes cloned in pCA24N from the ASKA library 197 
(39) induced by 0.01mM IPTG.  198 
 199 
Metabolic assays 200 
After culture, residual urine samples were separated into cell fraction and cell free 201 
supernatant by differential centrifugation and urine supernatants were filtered with a 0.2µm 202 
membrane to remove any remaining bacteria and stored at -80°C. Urine supernatants and 203 
culture supernatants were assayed for ethanolamine, acetate and ethanol by HPLC using an 204 
Agilent 1200 HPLC system with a refractive index detector. Urines collected from CUH and 205 
bacterial culture supernatants were filter sterilised at 0.2µm to remove bacteria before being 206 
stored at -80°C until the day of experimentation. Ethanolamine was measured by gradient 207 
HPLC after derivatisation with o-phthaldialdehyde (OPA) using a method adapted from 208 
Sturms et al. (40). The mobile phase consisted of Buffer A [10% methanol (Sigma-Aldrich) -209 
90% 10mM Na3PO4 (pH7.3) (Sigma-Aldrich)], and Buffer B [80% Methanol- 20% 10mM 210 
Na3PO4 (pH7.3)]. Samples were prepared using an in-loop derivatization reaction where 6µl 211 
of sample were taken up followed by 6µl 10mg/ml OPA and 3-mercaptopropionic acid in 212 
0.4M boric acid (Agilent Technologies) and incubated at room temperature for 3 minutes. 213 
The samples were injected into a 4.6 by 100mm, 2.7µm pore Infinity Lab Poroshell HPH-214 
C18 column (Agilent Technologies) and eluted with 5ml linear gradient from 50% Buffer B 215 
to 100% Buffer B followed by 5mls of 100% Buffer B at as constant flow rate of 1ml min
-1
. 216 
The excitation was detected at 224nm. A standard curve was created before each sequence 217 
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 10 
run. Identification of the peak and quantification was determined by comparison to retention 218 
time and standard curve.  219 
Acetate and ethanol were measured by the same HPLC system. 10µl of sample was injected 220 
into a REZEX 8µm 8% H, Organic Acid Column (Phenomenex, USA) and eluted with 15ml 221 
of 0.01M H2SO4 at a flow rate of 0.6ml min
-1
. The column was maintained at 65°C for the 222 
duration of the experiments. The identification of the substrate was determined by 223 
comparison of retention time to pure compound and concentrations were quantified by 224 
comparison to known standards. 225 
 226 
Transmission Electron Microscopy (TEM) 227 
This was carried out as previously described (41) After growth (as indicated in the text) 228 
bacteria cells were pelleted by centrifugation, to give a pellet no larger than 100µl in volume. 229 
The bacterial pellet was fixed in 2ml of 2.5% glutaraldehyde (Fluka) diluted in 0.1M Sodium 230 
cacodylate pH 6.8 (CAB) (bioWORLD). After incubation overnight at 4°C, bacteria were 231 
washed twice with 0.1 M CAB and suspended in fresh 2ml of 2.5% glutaraldehyde diluted in 232 
CAB. The bacteria were stained for 1 hour in 1 ml of 1% osmium tetroxide (w/v) (250µl 4% 233 
osmium tetroxide; 250 µl Milli-Q H2O; 500 µl 0.2 M CAB). The pellets were washed in 2ml 234 
Milli-Q H2O for 10 minutes twice before the pellets were dehydrated. Pellets were 235 
dehydrated through an ethanol (EtOH) gradient as follows: 50% EtOH (v/v) x 10mins; 70% 236 
EtOH x 10min; 90% EtOH x 10mins; 100% EtOH x 10mins three times and then the 237 
bacterial pellets were washed twice in propylene oxide for 10mins. The pellets were 238 
embedded into 1.5 ml propylene oxide: LV resin at 1:1 for 30 min followed by incubation 239 
2 × 1.5 h in 100% freshly made agar LV resin. The pellets were resuspended in 1ml of 100% 240 
LV resin and transferred to a conical bottom tube. The bacterial pellet was centrifuged at 241 
1100xg for 5mins and was left to incubate at 60°C for 24 hours. Bacteria were sectioned to 242 
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 11 
60-70 nm with a diamond knife on a LEICA-EM-UC7 ultramicrotome. Sections were 243 
collected on 400 mesh copper grids and stained with 4.5% (w/v) uranyl acetate in 1% acetic 244 
acid (v/v) for 45mins and Reynolds lead citrate for 7 mins at room temperature. Sections 245 
were then observed on a Jeol 1230 transmission electron microscope operated at an 246 
accelerating voltage of 80kV and imaged with a Gatan OneView digital camera.  247 
  248 
DNA sequencing and sequence analysis, statistics 249 
DNA was extracted from overnight cultures in LB and extracted using Qiagen DNEasy 250 
Blood and Tissue (Qiagen) with RNase A treatment (Sigma). Bacterial genome sequencing 251 
was carried out by MicrobesNG (see acknowledgements) using Illumina HiSeq 2500 252 
2x250bp paired-end reads. Reference genomes were identified using Kraken (42) and reads 253 
mapped using BWA-MEM (43). De novo read assembly was achieved using SPAdes (44), 254 
with read mapping back to the resultant contigs, using BWA-MEM for quality metrics. 255 
Automated annotation was performed using Prokka (45). Sequencing data are available for 256 
download from the EBI European Nucleotide Archive under BioProject accessions 257 
PRJEB31941, PRJEB31942, PRJEB31943, and PRJEB31944.  258 
 259 
Phylogenetic trees were generated from contig sequences with Parsnp (Harvest tool suite 260 
(46)) and edited with ITOL (47). Parsnp produces a core genome alignment and identifies 261 
SNPs for tree generation by FastTree2 (48) using SH-like (Shimodaira-Hasegawa) local 262 
supports for bootstrapping. Alignment with 32 reference genomes known to be representative 263 
of six E. coli phylogroups (49) was used for phylogroup assignment. Gene presence in 264 
genomes was taken as >75% identity in BLASTN search over the full reference gene 265 
sequence length. Binary matrices were prepared representing sequenced genomes with PUF 266 
gene presence scored as 1 and absence as zero, and phenotypic antimicrobial resistance 267 
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 12 
scored as 1 and sensitivity as zero. Two-dimensional cluster analysis on these matrices was 268 
performed with the R software package using complete linkage clustering on the Jaccard 269 
Distance. The resulting cladograms and heat maps were visualised with ITOL (47). All other 270 
statistical analyses presented were generated with GraphPad Prism 7.  271 
 272 
RNA and RT-PCR 273 
RNA was extracted from bacterial pellets using the Zymo Fungal/Bacterial Mini Prep kit and 274 
from Eukaryotic cells using the Quick-RNA MiniPrep kit, following the manufacturer’s 275 
instructions. After extraction genomic DNA was digested using the TURBO DNA-free 276 
(Ambion) DNase 1 treatment. The RNA was quantified using a Nanodrop 1000 277 
spectrophotometer. cDNA was synthesised by reverse transcription carried out in nuclease 278 
free 96-well plates. RNA was diluted using molecular grade H2O (Sigma-Aldrich) to a final 279 
concentration from of 100ng µl
-1
 in a 10µl volume. The RNA was mixed with: cDNA 280 
reaction was set up 4l 5x Reverse transcription buffer (Roche); 3l Random Hexamer 281 
Primer (Roche); 2l 20mM dNTPs mix; and 1l Reverse transcriptase/RNase Inhibitor to 282 
give a total volume of 20µl. The reaction mixture was incubated in a thermocycler in the 283 
following condition: 10mins at 25 °C; 30mins 55 °C; 5mins at 85 °C; hold at 4 °C. The 284 
cDNA was then diluted to 100µl and stored at -20 °C until use.  285 
 286 
The universal probe library (Roche, Indianapolis USA) was utilized to design primers for 287 
quantitative PCR. The primers used in this study are listed in Data Supplement Table S1 288 
Amplification reactions were a mix of: 3µl of cDNA; 7µl TaqMan Probe Master buffer 289 
(Roche); 1µl 20mM primer mix (L+R primers); 0.1µl probe(Roche);and 0.9 µl molecular 290 
grade H2O to a make a final volume of 10 µl. When the probe was not available a SYBR 291 
Green master mix was used which included: 3 µl cDNA, 5 µl 2xSYBR Green I Master buffer 292 
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 13 
(Roche); 1µl 20mM primer mix(L+R primers) and 1µl molecular grade H2O to a final 293 
volume of 10 µl. All reactions were performed using a 384 well plate on the 294 
LightCycler®480 System (Roche) with molecular grade water included as a negative control. 295 
Thermal cycling condition were as follows: 50°C for 2 mins, 95°C for 10 mins followed by 296 
45 cycles for 95°C for 10s, 60°C for 45 s and 72°C for 60 s. Relative gene expression was 297 
calculated using the 2-ΔΔCt (50). X-fold changes in mRNA of target gene was quantified 298 
relative to gyrA.  299 
 300 
ELISA  301 
Frozen urines were analysed using Meso Scale Discovery (MSD) V-PLEX proinflammatory 302 
panel I and Cytokine Panel II (MSD, Rockville, MD) enzyme-linked immunosorbent assays 303 
(ELISAs). Assays were performed according to the manufacturer’s instructions and measured 304 
using MESO QuickPlex SQ120. Calibrators were run in duplicate with the urines and used to 305 
form a standard curve. The concentration of cytokines in the urine were extrapolated from the 306 
standard curve. Values which fell below the limits of detection were excluded from statistical 307 
analysis.  308 
 309 
Results 310 
Ethanolamine is present in urine and infecting E. coli strains show eut operon induction 311 
One hundred and three clinically infected urine samples were selected from which 61 E. coli 312 
strains were isolated, 47 of which were sequenced and used for in vitro metabolic analysis. 313 
The mean concentration of ethanolamine in 54 clinically infected urine samples was 0.55 314 
mM (mean ±0.076) and 0.66 mM (mean ±0.155) in 12 control urine samples which were not 315 
clinically infected (contained no white cells or bacteria on microscopy) (Figure 1B). The 316 
difference between infected and control urines was not significant. In 24 E. coli infected 317 
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 14 
urine samples from which RNA was extracted, transcription of eut operon genes was detected 318 
in the majority of cases for eutB (88%) eutS (68%) and eutR (63%). Expression of eutB 319 
significantly correlated with the ethanolamine concentration in urine (Fig. 1C). Because of 320 
anonymisation individual patient details are not available. Audit of diagnostic urine 321 
specimens in our laboratory shows that 75% come from general practice, 25 % from hospital 322 
sources, and 75% overall from women. 323 
 324 
Clinically infected urine samples show stimulation of the host innate immune response . 325 
Cytokines IL-8 and IL-1 were detected in 81% of clinically infected urine samples and 326 
significantly increased in infected urines compared to non-infected urine (IL-1β P=0.0048, 327 
and IL-8 P<0.001, see Fig. S1 Supplemental material). Mean IL-6 levels were higher in 328 
infected urine than in non-infected urine but the difference was not significant (Data 329 
Supplement Fig. S1). 330 
 331 
Uropathogenic E. coli strains utilise ethanolamine in vitro resulting in enhanced growth, 332 
formation of bacterial microcompartments, and production of acetate and ethanol 333 
Forty-five out of 47 (96%) E. coli strains isolated from urine showed increased overnight 334 
growth with 10 mM ethanolamine as the sole nitrogen source in M9 minimal medium (Data 335 
Supplement Fig. S2). No increased growth was detected with 10 mM ethanolamine as a sole 336 
carbon source in M9 for four strains shown to actively metabolise ethanolamine as a nitrogen 337 
source (Data Supplement Fig.S2, S3). For these selected strains (U1, U13, U17, U38) growth 338 
in M9 medium with ethanolamine containing glycerol as a carbon source commenced after 339 
10 hours (Fig. 2A) with ethanolamine consumption from around eight hours (Fig. 2C). 340 
Addition of 10 mM ethanolamine to artificial urine medium (AUM) also increased growth of 341 
these strains (Fig. 2B) with consumption of ethanolamine from around four hours incubation 342 
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onwards (Fig. 2D). Acetate and ethanol were produced by E. coli U1 growth in both M9 and 343 
AUM media when ethanolamine was added (Fig. 2C,D) and corresponded with induction of 344 
the eut operon at 4 and 8 hours of incubation with ethanolamine in AUM (Data Supplement 345 
Fig. S4). TEM of E. coli U1 grown in AUM with added ethanolamine showed 100-130 nm 346 
cytoplasmic inclusions with straight edges (Fig. 3A) in the majority of cells visualised (43/69 347 
= 62%). These structures are typical of bacterial microcompartments. They were not 348 
observed in cells grown in the absence of ethanolamine (Fig. 3B) and were seen in a minority 349 
of cells grown in minimal medium with ethanolamine (Supplementary data Fig. S5). The 350 
difference in TEM appearances between M9 and AUM medium may be growth phase-351 
related. Cells were collected for TEM at 8 hours incubation which is approximately the 352 
starting time for ethanolamine consumption in M9 minimal medium, but the time of most 353 
rapid consumption in AUM (Fig. 2). Acetate was detected in nearly all infected urine samples 354 
tested (Supplementary Data Fig. S8). 355 
 356 
The effect of inactivation of individual enzyme-encoding genes in the eut operon 357 
suggests ethanolamine growth stimulation in artificial urine medium is due to provision 358 
of an additional carbon source  359 
 360 
Mutation of the eut operon genes eutB and eutE was achieved in strain U1 (Table 1). eutB 361 
encodes the heavy chain component of ethanolamine ammonia lyase required to liberate 362 
ammonia from ethanolamine, and eutE encodes a reversible acetaldehyde dehydrogenase, 363 
acting after eutBC in the ethanolamine catabolism pathway (see schematic, Fig. 1A). EutE is 364 
required to generate acetyl-CoA, which is the route for carbon assimilation from 365 
ethanolamine (Fig. 1A).  366 
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Growth stimulation in nitrogen-limited minimal (M9) medium by addition of ethanolamine 367 
(0.5 mM or 10 mM) was abolished by deletion of eutB in U1 and retained after deletion of 368 
eutE (Fig. 4A, 4B, Data Supplement Fig. S6, Table 2). RT-PCR showed that ethanolamine 369 
induced eutE transcription in the eutB mutant and vice versa, demonstrating that these were 370 
not polar mutations (Supplementary Data Fig. S4). Ammonia generation from ethanolamine 371 
alone is therefore sufficient to stimulate E. coli U1 growth in nitrogen-limited minimal (M9) 372 
medium. Complementation of the eutB mutant restored the wild-type phenotype in 373 
ethanolamine-containing minimal medium (Fig. 4A).  374 
In contrast to this phenotype in nitrogen-limited minimal (M9) medium, in AUM medium 375 
which contains 25 mM ammonium chloride and no glycerol as carbon source, growth 376 
stimulation by ethanolamine was absent in U1 ∆eutE, although ethanolamine was still 377 
metabolised by this strain (Fig. 4D,E, Table 2). Growth enhancement by ethanolamine in 378 
AUM was restored by eutE complementation. Therefore, in AUM, unlike nitrogen limited 379 
M9, the growth stimulation conferred by ethanolamine metabolism is not due to ammonia 380 
generation, but appears to be caused by the provision of an additional carbon source from 381 
acetyl-CoA.  382 
A functional eut operon is essential for competitive growth of a UPEC strain in the 383 
presence of ethanolamine in vitro 384 
Competitive growth assays in AUM containing 10 mM ethanolamine between wild type E. 385 
coli strain U1 and ∆eutB and ∆eutE mutants showed a significant advantage for the wild-type 386 
after 32 hours (incorporating a 24-hour subculture) for both mutants (Fig. 5). The ∆eutE 387 
mutant showed a significant disadvantage from 12 hours onwards. The competitive index 388 
(CI) of both mutants at all time intervals from 12 hours onwards was less than 0.8 (Data 389 
Supplement Table S2) No significant difference was found in competitive growth between 390 
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wild type and mutants in AUM with 0.5 mM ethanolamine (Data Supplement Fig. S7) or in 391 
the absence of ethanolamine (data not shown).  392 
 393 
The eut operon is conserved in all UPEC strains sequenced while putative urovirulence 394 
factors and metabolic polymorphisms previously associated with UPEC are 395 
phylogroup-related  396 
A SNP-based tree from a core genome alignment of the 47 urine E. coli isolates and 32 397 
representative reference strains by Parsnp (46) assigned all urine strains to phylogroups (Fig. 398 
6). The largest single grouping of urine E. coli isolates was formed by 22 phylogroup B2 399 
strains (46%) (Fig.6), followed by 11 phylogroup D2 (23%), 7 A 15%), 4 B1(9%), 2 D1(4%) 400 
and one phylogroup E (2%). The tree shown used U7 from this study as the reference strain 401 
for SNPs and the core 79-genome alignment (47 from this study plus 32 phylogroup 402 
representatives) included 53% of the U7 genome. The same phylogroup assignments were 403 
found in trees generated with finished closed GenBank genome sequence strains from each 404 
phylogroup as the SNP reference strain, as expected (46).  405 
 406 
The presence of a set of 31 previously described (12) putative virulence factors (PUFs) 407 
determined by BLASTN searching was used to score each of the 47 E. coli genomes. These 408 
represented a compilation of genes previously found to be enriched in UTI E. coli strains 409 
compared to other E. coli (51–54). All 31 PUFs were found in the set of genomes and the 410 
median PUF count was 13 (range 2-25). Phylogroup B2 E. coli urine isolates had higher PUF 411 
counts than non-B2 strains (P < 0.001, Mann-Whitney U test) (Figure 7A). Hierarchical 412 
clustering of PUF carriage profiles showed PUF profile patterns related to B2 clade 413 
membership, while clustering of antimicrobial resistance phenotypic profiles showed no 414 
obvious phylogenetic relationship (Figure 7B).  415 
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 416 
Regarding metabolic features, the eut operon was conserved in all 47 strains (Fig. 6B). 417 
However, strain U71 contained a novel prophage in the same site as the CPZ-55 prophage 418 
insertion between eutA and eutB characteristic of E. coli MG1655 (55) and other K-12 419 
lineage strains (Fig. 1A). Genome sequencing of the knock-out strains U1 ∆eutB and ∆eutE , 420 
above, revealed the expected single gene deletions (marked by a kanamycin cassette).  421 
 422 
A short metE regulatory allele was present in 30 strains and a complete D-serine tolerance 423 
locus (dsdCXA) was present in 29 strains (Fig. 6B). All strains contained a complete 424 
yhaOMKJ D-serine sensory locus. B2 strains were more likely to possess a short metE 425 
regulatory allele and a complete dsdCXA locus than non-B2 strains (2-sided P <0.0001 and 426 
0.0022, respectively, Fisher's exact test).  427 
 428 
 429 
Discussion 430 
The E. coli strains isolated from urine in this study were phylogenetically similar to 431 
previously published urinary tract infection series, in that B2 and D2 were the commonest 432 
two phylogroups (56). We report a lower proportion of B2 strains (46%) (Fig. 6) than 433 
urosepsis and urinary tract infection studies from the USA and Spain (67%-69%) (12, 54, 57, 434 
58), a similar proportion to Slovenia (50%) (59), and more than Denmark (34%) (60) and 435 
China (19%) (56). The PUF profile association demonstrated with phylogroup B2 (Fig. 7) is 436 
consistent with previous findings from a set of urinary tract infection isolates from the 437 
USA (12). This study found that B2 strains not associated with urinary tract infection are also 438 
enriched for these genes and that PUF profile does not correlate with virulence in animal 439 
models of UTI (12). Phylogroup B2 strains are more likely than other phylogroups to 440 
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colonise the gut (61, 62) and these putative urovirulence factors may in fact be more 441 
important in the gut. Similarly, we found that the metabolic loci proposed to be helpful for 442 
growth in urine such as D-serine tolerance and short metE allele were also associated with 443 
phylogroup B2 (Fig. 6).  444 
 445 
In contrast the eut operon was conserved in all isolates (Fig.6) and the ability to utilise 446 
ethanolamine in vitro was observed in 96% of strains (Supplementary Data Fig. S2). This is 447 
not surprising, because the E. coli core genome includes the eut operon (26). Therefore, the 448 
presence of ethanolamine accessible in urine is potentially a significant nutritional resource 449 
for all phylogroups of UPEC.  450 
 451 
We found similar concentrations of ethanolamine in infected urine from patients 0.55 mM 452 
(mean ±0.076) and non-infected urine controls 0.66 mM (mean ±0.155) (Fig. 1B). The levels 453 
are consistent with previous reports on smaller numbers of samples from healthy controls 454 
using different methodology such as NMR (0.38 mM) (63) and LC/MS (0.47 mM) (64). The 455 
NMR study found ethanolamine in all 22 urine specimens processed (63). The lack of 456 
ethanolamine in a minority of our infected specimens (9/54, Fig.1B) may reflect limitations 457 
of the HPLC assay. The maximal ethanolamine concentration in bovine intestinal content 458 
(BIC,the filtered contents of jejunum and ileum), where enterohaemorrhagic E. coli has been 459 
shown to gain an in vitro competitive advantage by ethanolamine utilisation, is 2.2 mM (33). 460 
For comparison, D-serine is regarded as an abundant substrate for E. coli metabolism in 461 
human urine (65) where it has been reported at a mean concentration of 0.12 mM out of a 462 
total mean urine serine concentration of 0.33 mM (16).  463 
 464 
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We found evidence that ethanolamine in infected urine was sensed by E. coli with induction 465 
of the eut operon regulator eutR, and was being metabolised, with induction of the 466 
ethanolamine deaminase component eutB correlating with measured ethanolamine levels in 467 
urine (Fig. 1C,D). In vitro, UPEC strains produced acetate and ethanol when metabolising 468 
ethanolamine in both minimal medium and artificial urine medium (Fig. 2), as expected (Fig. 469 
1A) (66). Acetate was also detected in infected urine (Data Supplement Fig S8), as 470 
previously reported for infected urine samples with a variety of different bacterial causes 471 
(67). Acetogenic growth of E. coli in vivo is hypothesized to be an essential property in 472 
urinary tract infection (68, 69) and has been ascribed to metabolism of D-serine via pyruvate 473 
to acetyl-CoA and acetyl phosphate (68, 70). We propose the consistent presence of host-474 
derived ethanolamine in urine at higher concentrations than D-serine also contributes to this 475 
phenotype. Acetate is an important regulator of E. coli gene expression (70) and the host 476 
immune response (71) and may contribute to the previously reported (35) phenotype linking 477 
the eut operon to resistance to innate immunity.  478 
 479 
TEM revealed that cells metabolising E. coli in vitro in AUM produced numerous plane-480 
edged cytoplasmic inclusions typical of bacterial microcompartments (Fig. 3) in the majority 481 
of cells imaged. Although Eut microcompartments have been extensively imaged from 482 
Salmonella enteritidis, we are not aware of previous publications showing these from 483 
uropathogenic E. coli.  484 
 485 
Ethanolamine is not synthesized by mammals (72) and is obtained from the diet, with the 486 
ultimate source being plant and animal cell membranes. It is incorporated in 487 
phosphatidylethanolamine (PE), an aminophospholipid that is an essential constituent of cell 488 
membranes, particularly those of mitochondria and the endoplasmic reticulum (72). The 489 
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source for ethanolamine detected in urine has not been established. Cell lines in vitro release 490 
ethanolamine into culture medium from cell membrane turnover (73). Within the 491 
gastrointestinal tract available ethanolamine is assumed to derive from the breakdown of 492 
phospholipid from the turnover of the epithelium and dietary phospholipid (74). There is a 493 
constant supply of ethanolamine in urine in both health and infection (Fig. 1B) (63, 64), and 494 
the source in health seems unlikely to be cell turnover in the urinary tract, because this occurs 495 
at a relatively slow rate compared to the gastrointestinal tract. The cell membranes of 496 
neutrophils and bladder epithelial cells are additional potential sources in infected urine. 497 
 498 
There is some evidence to regard E. coli as relatively nitrogen limited in the urinary tract 499 
because it lacks urease to metabolise the most abundant nitrogen source in urine. Induction of 500 
the high-ammonium affinity glutamine synthase and glutamate oxo-glutarate 501 
aminotransferase pathway (GS/GOCAT) for nitrogen assimilation occurs in E. coli infected 502 
urine (69, 75).  503 
 504 
Because ethanolamine metabolism yields ammonia and acetate (Fig. 1A), in theory it should 505 
promote E. coli growth as either a sole carbon or nitrogen source. E. coli utilisation of 506 
ethanolamine as a sole nitrogen source in minimal media has been reported at concentrations 507 
of 30 mM (33). We found that 96 % of clinical UPEC strains showed utilisation of 10 mM 508 
ethanolamine as a sole nitrogen source (Fig. 2A, Data Supplement Fig.S3A). Contradicting 509 
the assertion that concentrations of ethanolamine below 1 mM (76) do not support growth of 510 
E. coli, we found that 0.5 mM, the level present in urine, could sustain small amounts of E. 511 
coli growth in nitrogen limited media (Supplementary Data Fig. S2, S6A). Utilisation of 512 
ethanolamine by E. coli strains as a sole carbon source in vitro is reported to require a high 513 
ethanolamine concentration (1 g l
-1
, 82 mM) (77). Even at this concentration some strains 514 
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showing active ethanolamine metabolism, for example the O157:H7 EHEC strain EDL933, 515 
have been reported as unable to use ethanolamine as a sole carbon source (33). Likewise, we 516 
found no in vitro growth promotion of known-ethanolamine metabolising UPEC strains by 517 
10 mM ethanolamine in carbon limited minimal media (Data Supplement Fig S3B). 518 
However, in artificial urine medium (AUM) where the nitrogen sources are urea and 519 
ammonia, and the carbon sources are amino acids, lactate and citrate (36), ethanolamine at 10 520 
mM and 0.5 mM (Fig 2B, 4B, 4C, Data Supplement Fig. S6B) promoted additional growth of 521 
E. coli.  522 
 523 
In M9 nitrogen limited media the phenotype of eutE mutants showed that the ammonia 524 
liberated by the first reaction in ethanolamine metabolism catalysed by eutBC (Fig.1A) was 525 
sufficient for growth (Fig. 4B, Supplementary Data Fig. S6A). However, this was not 526 
sufficient for growth stimulation by ethanolamine in AUM where eutE was also required 527 
(Fig. 4D), suggesting generation of acetyl-CoA as an additional carbon source was 528 
responsible for additional growth in this medium. A second pathway for ethanolamine 529 
conversion to acetyl CoA has been predicted (but not defined) in Salmonella enterica from 530 
the ability of eutBC mutants to grow on ethanolamine as a carbon source in the presence of 531 
concentrations of carbon dioxide sufficient to change intracellular pH (31), but no carbon 532 
dioxide was provided in our experiments.  533 
 534 
The observation that ethanolamine at 10 mM confers a competitive growth advantage on a 535 
wild type UPEC strain co-cultured with ∆eutE and ∆eutB mutants in artificial urine media 536 
(Fig. 5) also supports a role for acetyl-CoA generation in growth enhancement, because 537 
extracellular acetate or ammonia deriving from wild-type cells metabolising ethanolamine is 538 
apparently insufficient to confer growth enhancement on mutants in this medium. In contrast, 539 
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E. coli strains engineered for enhanced takeup of amino acids to grow faster on amino acids 540 
than a wild type strain when cultured in isolation, lose any growth advantage in co-culture 541 
with the wild type (78). This is because of extracellular ammonia leak from enhanced amino 542 
acid metabolism in the engineered strains providing nitrogen to the wild-type strain (78).  543 
 544 
Although we did not demonstrate a competitive advantage of wild-type E. coli over eut 545 
operon mutants in co-culture in a physiological ethanolamine concentration of 0.5 mM (Data 546 
Supplement Fig. S7), this may well be due to methodological limitations. Following a 4 hour 547 
lag period, ethanolamine is removed from AUM medium by E. coli at a rate of approximately 548 
0.75 mM per hour (Fig. 2D), so any selective advantage due to 0.5 mM ethanolamine must be 549 
necessarily brief and difficult to detect in a competition assay based on batch culture. 550 
However, in vivo, host-derived ethanolamine would be continuously passing into urine at the 551 
same time as bacterial ethanolamine catabolism. The level of ethanolamine seen in non-552 
infected urine is maintained in infected urine (Fig. 1B) containing large numbers of E. coli 553 
with induced eut operons (Fig. 1C,D), suggesting it is an equilibrium level. The assertion that 554 
concentrations of ethanolamine below 1 mM (76), the level present in urine, do not support 555 
growth of E. coli is contradicted by our in vitro data in both minimal medium where 556 
ethanolamine functions as the sole nitrogen source (Fig. S6A) and the complex AUM where 557 
it appears to function as a carbon source additional to amino acids (Fig 6B). Ethanolamine in 558 
urine is an important nutritional resource that infecting uropathogenic E. coli can access to 559 
augment growth by microcompartment-mediated metabolism. These conserved metabolic 560 
pathways and structures distinct from the host offer opportunities for detection and treatment 561 
of infection.  562 
 563 
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Tables 579 
 580 
Table 1 Plasmids and strains in this study 581 
 582 
 583 
 584 
 585 
 586 
  587 
 Genotype/designation Source 
Plasmids   
pCA24N High copy number expression 
vector, cat 
NBRP E.coli, Japan  
(39) 
pCA24N::eutB ASKA clone JW2434 “ 
pCA24N::eutE ASKA clone JW2439 “ 
Strains   
E. coli U1 E.coli Phylogroup A urine 
isolate 
This study 
E.coli JW2434-1 BW25113∆eutB Keio collection, 
Japan (37) 
E.coli JW2439-1 BW25113∆eutE “ 
E. coli U1∆eutB ∆eutB::kan This study 
E. coli U1∆eutE ∆eutE::kan This study 
U2-U79 (46 strains) E. coli urine isolates.  This study  
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Table 2 In vitro growth phenotype of wild type U1 and eut operon mutants with 588 
additional ethanolamine (Eth) 589 
 590 
Genotype M9 
10mM Eth 
M9 
0.5mM Eth 
AUM 
10mM Eth 
AUM 
0.5mM Eth 
U1 wild type + + + + 
U1∆eutB — — — — 
U1∆eutE + + — — 
U1∆eutB/ 
pCA24N::eutB 
+ + + ND 
U1∆eutE/ 
pCA24N::eutE 
+ + + ND 
 591 
 592 
+ growth enhancement compared to growth without ethanolamine. — no growth 593 
enhancement compared to growth without ethanolamine. *Growth enhancement only 594 
observed after 30 hours. ND no data. M9 minimal medium, AUM Artificial Urine Medium. 595 
  596 
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Figure Legends Dadswell et al 834 
 835 
Figure 1. Ethanolamine is present in urine and urinary ethanolamine concentration 836 
correlates with expression of eut operon genes in E. coli infected urine 837 
A. Microcompartment-mediated ethanolamine metabolic pathway and eut operon: black 838 
arrows metabolite translocation or reaction, dotted arrows metabolite translocation impeded 839 
by microcompartment, blue hexagon microcompartment, microcompartment associated 840 
enzymes in blue, cytoplasmic enzymes in black. Yellow arrows below show the eut operon 841 
(red arrow at prophage insertion hot spot). B. Ethanolamine concentration in urine. There is 842 
no significant difference in ethanolamine concentration between clinically infected urine 843 
samples and control non-infected samples (Mann-Whitney U-test). C. Correlation between 844 
ethanolamine concentration in infected urine and expression of eutB (relative to gyrA), 845 
Spearman's rank correlation coefficient r=0.815, ***p <0.001. D. Correlation between 846 
ethanolamine concentration in infected urine and expression of eutR (relative to gyrA), 847 
Spearman's rank correlation coefficient r=0.423. 848 
 849 
Figure 2. Ethanolamine metabolism promotes UPEC growth in nitrogen-limited 850 
minimal medium and Artificial Urine Medium (AUM). 851 
Aerobic growth of selected UPECs at 37 °C in: (A) ammonia-free modified M9 media with 852 
glycerol (20mM) (B) AUM. Hollow data points are without ethanolamine, solid data points 853 
with additional 10mM Ethanolamine. Concentration of ethanolamine (Eth) (green), acetate 854 
(red) and ethanol (blue) over time during U1 growth in (C) ammonia-free M9 media with 855 
glycerol (20mM) and (D) AUM, both supplemented with an initial 10mM ethanolamine. 856 
Values are Mean ± SEM. N≥3. 857 
 858 
 o
n
 June 21, 2019 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
 38 
Figure 3. Growth of UPEC strain U1 in Artificial Urine Medium with ethanolamine 859 
promotes formation of bacterial microcompartments.  860 
Transmission electron microscopy following culture for eight hours. A. in AUM with 10 mM 861 
ethanolamine. B. In AUM alone. White arrows indicate microcompartments.  862 
 863 
Figure 4. eutE inactivation in UPEC strain U1 abolishes ethanolamine growth 864 
stimulation in AUM medium despite preserved ethanolamine catabolism 865 
A. Growth of U1, U1 ∆eutB mutant and complement in modified M9 plus 10 mM 866 
ethanolamine. B. Growth of U1, U1∆eutE mutant and complement in modified M9 with 10 867 
mM ethanolamine. C. Growth of U1, U1 ∆eutB mutant and complement in AUM plus 10 868 
mM ethanolamine. D. Growth of U1, U1∆eutE and complement in AUM with 10 mM 869 
ethanolamine. In A-D growth of U1 in control medium without ethanolamine is shown as 870 
open circles. E. Percentage change in ethanolamine concentration measured by HPLC over 871 
24 hours of U1, U1∆eutB and U1∆eutE, and their complements in AUM with initial 10mM 872 
ethanolamine. Significant difference with wild-type*** P<0.001 , 1-way ANOVA. All 873 
Values are Mean ± SEM. N=3 874 
 875 
Figure 5. Inactivation of eut operon genes reduces competitiveness of E. coli UPEC 876 
strain U1 in artificial urine medium containing 10 mM ethanolamine 877 
Competition of U1 vs A: U1∆eutB with 10mM ethanolamine, B: U1∆eutE with 10mM 878 
ethanolamine. Mann-Whitney U test . *p<0.05, **p<0.01, ***p<0.001. Values are Mean ± 879 
SEM. N=3. 880 
 881 
Figure 6. Phylogenetic distribution of E. coli urine isolates from this study and 882 
conservation of metabolic operons 883 
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A. The phylogeny of 47 strains (taxon labels in red) isolated from infected urine analysed by 884 
core genome alignment using Parsnp with 32 reference strains representative of six E.coli 885 
phylogroups (taxon labels in black). Bootstrap values for all internal nodes were 1.0 apart 886 
from the node (0.25) between the reference strains APECO1 and IHE3034, which constitute 887 
the least diverged core genome pair in the reference set. Clade assignments shown in the 888 
vertical bar on the right. B. Parsnp alignment of the 47 strains alone, B2 phylogroup coloured 889 
blue. Vertical bars/circles indicate presence of a complete eut operon (red), a complete 890 
dsdCXA locus (green), and a short regulatory metE allele (grey) in each strain 891 
 892 
Figure 7 Carriage of PUFS (putative virulence factors) but not antimicrobial resistance 893 
is associated with clade B2 E. coli urine isolates 894 
A. PUF scores differ between B2 and non-B2 groups. Mann-Whitney U test *** p<0.0001 895 
B. Antimicrobial resistance scores (number of different antimicrobials to which the strain is 896 
resistant) does not differ between B2 and non-B2 groups 897 
C. Genome sequences of clinical urine E.coli isolates were screened for the presence of 31 898 
previously-described PUFs (y-axis labels) using BLASTN. Presence (black squares) or 899 
absence (grey squares) is shown for each PUF in relation to each isolate. Two dimensional 900 
hierarchical clustering shows PUF co-occurrence by strain (upper y-axis dendrogram) and 901 
PUF association with phylogeny (x-axis dendrogram). Clade B2 strains are indicated by 902 
white names on a black background (x-axis labels). Lower diagram shows hierarchical 903 
clustering of resistance (dark grey squares) and sensitivity (pale grey squares) to nine 904 
different antimicrobials (lower y-axis dendrogram) by strain phylogeny. Abbreviations as 905 
follows: Gent, Gentamicin; Nitro, Nitrofurantoin; Cipro, Ciprofloxacin; Levo, Levofloxacin; 906 
Tetra, Tetracycline; Cotrim, Cotrimoxazole; PipTaz, Piperacillin/tazobactam; Amp, 907 
Ampicillin; Coamox , Amoxicillin/clavulanic acid.  908 
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